A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, multi-dose, parallel group trial which will assess the
pharmacodynamic response of fluticasone propionate and formoterol fumarate in subjects with
COPD.